IP Library Granted Patent US 8,962,827
Granted Patent B2
US 8,962,827 · App. 14/008,124 · Granted Feb 24, 2015

Linezolid intermediate and method for synthesizing linezolid

Inventors: Xiaoyue Jiang (Chengguan Town, CN); Guofeng Wu (Chengguan Town, CN); Weidong Ye (Chengguan Town, CN); Runpu Shen (Chengguan Town, CN); Xiaohua Song (Chengguan Town, CN)
Assignee: Zhejiang Medicine Co. Ltd. Xinchang Pharmaceutical Factory
C07C233/18C07D263/20C07D413/10C07C231/12C07D263/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,962,827
App. No.
14/008,124
Granted
Feb 24, 2015
Kind
B2
Abstract

Provided are a linezolid intermediate and the preparation method thereof and a method for synthesizing linezolid. The structure of the intermediate is shown as formula F2, wherein the compound is prepared by a condensation reaction of (S)—N-(3-chloro-2-hydroxy-1-propyl) acetamide and the compound shown in formula F4. In the preparation methods of the compound shown in formula F2 and linezolid, the reaction system is mild, side reactions are few and the product yield is high.

Claims (22)

1. A compound of formula F2,

wherein R is hydrocarbon group.

2. The compound according to claim 1 , wherein R is alkyl or aryl.

3. The compound according to claim 1 , wherein R is methyl, ethyl, propyl or benzyl.

4. A method for preparing the compound according to claim 1 , wherein the compound is prepared by a condensation reaction of (S)—N-(3-chloro-2-hydroxy-1-propyl)acetamide with the compound of formula F4:

wherein R is hydrocarbon group, preferably alkyl or aryl, more preferably methyl, ethyl, propyl or benzyl.

5. The preparation method according to claim 4 , characterized in that the molar ratio of the compound of formula F4 to (S)—N-(3-chloro-2-hydroxy-1-propyl)acetamide is 1:1.1˜1.3.

6. The preparation method according to claim 4 , characterized in that the condensation reaction is carried out in the presence of a deacid reagent.

7. The preparation method according to claim 6 , characterized in that the deacid reagent is an organic amine or an inorganic base.

8. The preparation method according to claim 7 , characterized in that the organic amine is triethylamine, pyridine, and the inorganic base is potassium carbonate or sodium carbonate.

9. The preparation method according to claim 6 , characterized in that the molar ratio of the compound of formula F4 to the deacid reagent is 1:1.1˜1.5.

10. The preparation method according to claim 4 , characterized in that the condensation reaction is carried out in the presence of an inert solvent or a dipolar aprotic solvent.

11. The preparation method according to claim 10 , characterized in that the inert solvent is halohydrocarbon, preferably dichloromethane, chloroform, dichloroethane or chlorobenzene; and the dipolar aprotic solvent is tetrahydrofuran, N,N-dimethylformamide, N,N-dimethylacetamide or acetone.

12. The preparation method according to claim 10 , characterized in that the mass ratio of the inert solvent or dipolar aprotic solvent to (S)—N-(3-chloro-2-hydroxy-1-propyl)acetamide is 3˜5:1.

13. The preparation method according to claim 4 , characterized in that the condensation reaction is carried out at a temperature of 10° C.-40° C., preferably 15˜30° C.

14. A method for synthesizing linezolid, wherein the condensation reaction of 3-fluoro-4-morpholinylaniline with the compound of formula F2 is carried out in the presence of an inert solvent, to obtain linezolid:

wherein R is hydrocarbon group, preferably R is alkyl or aryl, more preferably methyl, ethyl, propyl or benzyl.

15. The method according to claim 14 , characterized in that the molar ratio of the compound of formula F2 to 3-fluoro-4-morpholinylaniline is 1.1˜1.3:1.

16. The method according to claim 14 , characterized in that the reaction is carried out in the presence of an inert solvent or a dipolar aprotic solvent.

17. The method according to claim 14 , characterized in that the inert solvent is halohydrocarbon, preferably dichloromethane, chloroform, dichloroethane or chlorobenzene; and the dipolar aprotic solvent is tetrahydrofuran, N,N-dimethylformamide, N,N-dimethylacetamide or acetone.

18. The method according to claim 14 , characterized in that the mass ratio of the inert solvent or dipolar aprotic solvent to 3-fluoro-4-morpholinylaniline is 5˜10:1.

19. The method according to claim 14 , characterized in that the reaction is carried out at a temperature of 100˜160° C.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2018
From: ZHEJIANG MEDICINE CO. LTD. XINCHANG PHARMACEUTICAL FACTORY
To: ZHEJIANG CHANGHAI PHARMACEUTICAL CO. LTD.
Reel/Frame 046250/0894 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2013
From: JIANG, XIAOYUE; WU, GUOFENG; YE, WEIDONG; SHEN, RUNPU; SONG, XIAOHUA
To: ZHEJIANG MEDICINE CO. LTD. XINCHANG PHARMACEUTICAL FACTORY
Reel/Frame 031299/0655 →
Continuity (1)
Related Publication 20140024827A1 · Jan 23, 2014